| Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations H Andrikovics, T Krahling, K Balassa, G Halm, A Bors, M Koszarska, ... haematologica 99 (7), 1184, 2014 | 144 | 2014 |
| Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or … DW Beelen, R Trenschel, M Stelljes, C Groth, T Masszi, P Reményi, ... The Lancet Haematology 7 (1), e28-e39, 2020 | 115 | 2020 |
| Complement overactivation and consumption predicts in-hospital mortality in SARS-CoV-2 infection G Sinkovits, B Mező, M Réti, V Müller, Z Iványi, J Gál, L Gopcsa, ... Frontiers in immunology 12, 663187, 2021 | 102 | 2021 |
| Tandem autologous stem cell transplantation improves outcomes in newly diagnosed multiple myeloma with extramedullary disease and high-risk cytogenetics: a study from the … N Gagelmann, DJ Eikema, L Koster, D Caillot, P Pioltelli, JB Lleonart, ... Biology of blood and marrow transplantation 25 (11), 2134-2142, 2019 | 72 | 2019 |
| Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy‐driven survey J Sinko, J Csomor, R Nikolova, S Lueff, G Krivan, P Remenyi, A Batai, ... Transplant Infectious Disease 10 (2), 106-109, 2008 | 71 | 2008 |
| Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the … J Pavlů, M Labopin, R Niittyvuopio, G Socié, I Yakoub-Agha, D Wu, ... Journal of hematology & oncology 12, 1-9, 2019 | 59 | 2019 |
| Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: a retrospective analysis by the chronic malignancies … N Polverelli, K Mauff, N Kröger, M Robin, D Beelen, D Beauvais, ... American journal of hematology 96 (1), 69-79, 2021 | 51 | 2021 |
| Reduction in the frequency of transplant-related complications in patients with chronic myeloid leukemia undergoing BMT preconditioned with a new, non-myeloablative drug … E Kelemen, T Masszi, P Remenyi, A Barta, K Paloczi Bone marrow transplantation 21 (8), 747-749, 1998 | 48 | 1998 |
| The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report … M Schmidt-Hieber, G Tridello, P Ljungman, M Mikulska, N Knelange, ... Annals of hematology 98, 1755-1763, 2019 | 44 | 2019 |
| Additional chromosome abnormalities, BCR-ABL tyrosine kinase domain mutations and clinical outcome in Hungarian tyrosine kinase inhibitor-resistant chronic myelogenous leukemia … N Meggyesi, A Kozma, G Halm, S Nahajevszky, Á Bátai, S Fekete, A Barta, ... Acta Haematologica 127 (1), 34-42, 2011 | 42 | 2011 |
| The potential role of HLA-DRB1* 11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy K Balassa, H Andrikovics, P Remenyi, A Batai, A Bors, KP Kiss, A Szilvasi, ... Bone Marrow Transplantation 50 (10), 1321-1325, 2015 | 34 | 2015 |
| CIDP cured by allogeneic hematopoietic stem cell transplantation P Remenyi, T Masszi, Z Borbenyi, J Soos, L Siklos, JI Engelhardt European Journal of Neurology 14 (8), e1, 2007 | 34 | 2007 |
| Peripheral blood stem cell mobilization and engraftment after autologous stem cell transplantation with biosimilar rhG-CSF P Reményi, L Gopcsa, I Marton, M Réti, G Mikala, M Pető, A Barta, A Bátai, ... Advances in therapy 31, 451-460, 2014 | 33 | 2014 |
| Value of surveillance cultures in a bone marrow transplantation unit É Czirók, GY Prinz, R Dénes, P Reményi, A Herendi Journal of medical microbiology 46 (9), 785-791, 1997 | 32 | 1997 |
| Treosulfan compared with reduced‐intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome … DW Beelen, M Stelljes, P Reményi, EM Wagner‐Drouet, P Dreger, ... American journal of hematology 97 (8), 1023-1034, 2022 | 29 | 2022 |
| Quality of life and its socio‐demographic and psychological determinants after bone marrow transplantation H Janicsák, T Masszi, P Reményi, GS Ungvari, G Gazdag European journal of haematology 91 (2), 135-140, 2013 | 28 | 2013 |
| EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL) W Wiktor-Jedrzejczak, J Drozd-Sokolowska, DJ Eikema, J Hoek, M Potter, ... Bone marrow transplantation 54 (9), 1391-1398, 2019 | 27 | 2019 |
| Current trends in applications of circulatory microchimerism detection in transplantation H Andrikovics, Z Őrfi, N Meggyesi, A Bors, L Varga, P Kövy, Z Vilimszky, ... International Journal of Molecular Sciences 20 (18), 4450, 2019 | 26 | 2019 |
| Co-occurrence of myeloproliferative neoplasms and solid tumors is attributed to a synergism between cytoreductive therapy and the common TERT polymorphism rs2736100 T Krahling, K Balassa, KP Kiss, A Bors, A Batai, G Halm, M Egyed, ... Cancer Epidemiology, Biomarkers & Prevention 25 (1), 98-104, 2016 | 26 | 2016 |
| Successful nivolumab therapy in an allogeneic stem cell transplant child with post‐transplant lymphoproliferative disorder C Kassa, P Reményi, J Sinkó, K Kállay, G Kertész, G Kriván Pediatric Transplantation 22 (8), e13302, 2018 | 24 | 2018 |
